FIELD: biochemistry.
SUBSTANCE: invention relates to a humanised mouse which contains a nucleic acid sequence encoding a human protein M-CSF and operably linked to an endogenous promoter of a mouse M-CSF gene in a mouse M-CSF locus, as well as methods for producing it. Also disclosed are methods of screening substance for presence of activity, modulating function of human hematopoietic cells in humanized M-CSF mouse, using above described mouse.
EFFECT: invention enables efficient production of humanised mice expressing human protein M-CSF in bone marrow, spleen, blood, liver, brain, lungs, testis and kidney.
55 cl, 9 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
HUMANISED MOUSE M-CSF | 2012 |
|
RU2577978C2 |
HUMANIZED M-CSF MICE | 2020 |
|
RU2819731C2 |
GENETICALLY MODIFIED ANIMALS NOT RELATED TO HUMAN RACE AND THEIR APPLICATION METHODS | 2013 |
|
RU2775425C2 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS FOR USE THEREOF | 2013 |
|
RU2673156C2 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2799086C2 |
NON-HUMAN GENETICALLY MODIFIED ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2711744C1 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR APPLICATION | 2013 |
|
RU2642319C2 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR USE | 2013 |
|
RU2768282C2 |
MODEL OF HLA-INCOMPATIBLE HUMANIZED NSG MOUSE WITH XENOGRAFT OBTAINED FROM A PATIENT | 2016 |
|
RU2757421C2 |
HUMANISED MICE WITH SIRPA-IL15 NOKIN AND METHODS FOR USING THEM | 2016 |
|
RU2730599C2 |
Authors
Dates
2020-08-24—Published
2012-02-14—Filed